SLG
CSII

Stanley-Laman Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Stanley-Laman Group’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,482
Closed -$475K – 264
2020
Q1 		$475K Buy
+13,482
New +$568K 0.14% 180

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Stanley-Laman Group's CSII Position: Q2 2020 in Review

Stanley-Laman Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2020, closing a stake of 13,482 shares — an estimated $475K sold.

Stanley-Laman Group first reported a position in CSII in Q1 2020 and held it in 1 quarter. The position peaked at $475K in Q1 2020. 186 funds tracked by Wall St. Rank hold CSII as of Q2 2020.

  • Stanley-Laman Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2020 after selling out during the quarter.
  • Stanley-Laman Group sold 13,482 Cardiovascular Systems, Inc. shares in Q2 2020, an estimated $475K.
  • Stanley-Laman Group first reported a position in Cardiovascular Systems, Inc. in Q1 2020 and held it in 1 quarter.
  • Stanley-Laman Group's Cardiovascular Systems, Inc. position peaked at $475K in Q1 2020.
  • 186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2020.

Based on Stanley-Laman Group's 13F filing for Q2 2020, filed 20 Jul 2020.